In the last 12 months, insiders at INTERNATIONAL FLAVORS & FRAGRANCES INC ($IFF) filed 419 transactions with the SEC: 23 open-market purchases totaling $20,174,955 and 10 sales totaling $1,078,856. Net insider sentiment: net buying.
INTERNATIONAL FLAVORS & FRAGRANCES INC operates in the Industrial organic chemicals industry (Industrial Applications and Services sector).
Most Active Insiders
- FRIBOURG PAUL J (Director) — 12 transactions totaling $11,986,993
- Fyrwald J Erik (Chief Executive Officer) — 12 transactions totaling $7,708,237
- Arora Yuvraj (President, Taste & CCO) — 10 transactions totaling $2,963,477
- ICAHN BRETT (Director) — 3 transactions totaling $2,096,968
- Finzel Ralf (EVP, Global Operations Officer) — 25 transactions totaling $2,091,378
View all SEC Filings for INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Arora Yuvraj | President, Taste & CCO | M | Common Stock | 4305 | $0.00 | 17,742.0000 | 257,000,000 | 32.04% | 0.00% |
| April 1, 2026 | Arora Yuvraj | President, Taste & CCO | F | Common Stock | 2203 | $72.57 | 15,539.0000 | 257,000,000 | 12.42% | 0.00% |
| April 1, 2026 | Arora Yuvraj | President, Taste & CCO | A | Restricted Stock Units | 13780 | $0.00 | 33,839.0000 | 257,000,000 | 68.70% | 0.01% |
| April 1, 2026 | Arora Yuvraj | President, Taste & CCO | M | Restricted Stock Units | 4305 | $72.57 | 29,534.0000 | 257,000,000 | 12.72% | 0.00% |
| April 1, 2026 | Fyrwald J Erik | Chief Executive Officer | M | Common Stock | 18769 | $0.00 | 121,689.0000 | 257,000,000 | 18.24% | 0.01% |
| April 1, 2026 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 868 | $72.57 | 16,143.0000 | 257,000,000 | 5.10% | 0.00% |
| April 1, 2026 | Finzel Ralf | EVP, Global Operations Officer | A | Restricted Stock Units | 6890 | $0.00 | 18,642.0000 | 257,000,000 | 58.63% | 0.00% |
| April 1, 2026 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 2152 | $72.57 | 16,490.0000 | 257,000,000 | 11.54% | 0.00% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | M | Common Stock | 4305 | $0.00 | 4,305.0000 | 257,000,000 | 9999.99% | 0.00% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | M | Common Stock | 3013 | $0.00 | 7,318.0000 | 257,000,000 | 69.99% | 0.00% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | F | Common Stock | 1335 | $72.57 | 5,983.0000 | 257,000,000 | 18.24% | 0.00% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | F | Common Stock | 1908 | $72.57 | 4,075.0000 | 257,000,000 | 31.89% | 0.00% |
| April 1, 2026 | Fyrwald J Erik | Chief Executive Officer | M | Restricted Stock Units | 18769 | $72.57 | 135,433.0000 | 257,000,000 | 12.17% | 0.01% |
| April 1, 2026 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 2152 | $0.00 | 17,011.0000 | 257,000,000 | 14.48% | 0.00% |
| April 1, 2026 | Fyrwald J Erik | Chief Executive Officer | A | Restricted Stock Units | 66143 | $0.00 | 154,202.0000 | 257,000,000 | 75.11% | 0.03% |
| April 1, 2026 | Fyrwald J Erik | Chief Executive Officer | F | Common Stock | 8835 | $72.57 | 112,854.0000 | 257,000,000 | 7.26% | 0.00% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | A | Restricted Stock Units | 13780 | $0.00 | 35,735.0000 | 257,000,000 | 62.76% | 0.01% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | M | Restricted Stock Units | 3013 | $72.57 | 32,722.0000 | 257,000,000 | 8.43% | 0.00% |
| April 1, 2026 | Lourenco Leticia Goncalves | President, Health & Bioscience | M | Restricted Stock Units | 4305 | $72.57 | 28,417.0000 | 257,000,000 | 13.16% | 0.00% |
| April 1, 2026 | Birenkrant Marc | Controller & CAO | M | Common Stock | 473 | $0.00 | 9,814.3930 | 257,000,000 | 5.06% | 0.00% |
| April 1, 2026 | Birenkrant Marc | Controller & CAO | F | Common Stock | 171 | $72.57 | 9,643.3930 | 257,000,000 | 1.74% | 0.00% |
| April 1, 2026 | Birenkrant Marc | Controller & CAO | A | Restricted Stock Units | 2480 | $0.00 | 2,480.0000 | 257,000,000 | 9999.99% | 0.00% |
| April 1, 2026 | Birenkrant Marc | Controller & CAO | M | Restricted Stock Units | 473 | $72.57 | 2,007.0000 | 257,000,000 | 19.07% | 0.00% |
| April 1, 2026 | Muller Andres Roberto | President, Food Ingredients | M | Common Stock | 2583 | $0.00 | 3,775.0000 | 257,000,000 | 216.69% | 0.00% |
| April 1, 2026 | Muller Andres Roberto | President, Food Ingredients | F | Common Stock | 759 | $72.57 | 3,016.0000 | 257,000,000 | 20.11% | 0.00% |
| April 1, 2026 | Muller Andres Roberto | President, Food Ingredients | A | Restricted Stock Units | 12402 | $0.00 | 23,802.0000 | 257,000,000 | 108.79% | 0.00% |
| April 1, 2026 | Muller Andres Roberto | President, Food Ingredients | M | Restricted Stock Units | 2583 | $72.57 | 21,219.0000 | 257,000,000 | 10.85% | 0.00% |
| April 1, 2026 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Common Stock | 2030 | $0.00 | 36,268.0000 | 257,000,000 | 5.93% | 0.00% |
| April 1, 2026 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 819 | $72.57 | 35,449.0000 | 257,000,000 | 2.26% | 0.00% |
| April 1, 2026 | Borg Deborah | EVP, Chief Ppl&Culture Officer | A | Restricted Stock Units | 11024 | $0.00 | 25,182.0000 | 257,000,000 | 77.86% | 0.00% |
| April 1, 2026 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Restricted Stock Units | 2030 | $72.57 | 23,152.0000 | 257,000,000 | 8.06% | 0.00% |
| April 1, 2026 | Landsman Stephen N | EVP, General Counsel | M | Common Stock | 3228 | $0.00 | 18,328.0000 | 257,000,000 | 21.38% | 0.00% |
| April 1, 2026 | Landsman Stephen N | EVP, General Counsel | F | Common Stock | 1164 | $72.57 | 17,164.0000 | 257,000,000 | 6.35% | 0.00% |
| April 1, 2026 | Landsman Stephen N | EVP, General Counsel | A | Restricted Stock Units | 15158 | $0.00 | 24,844.0000 | 257,000,000 | 156.49% | 0.01% |
| April 1, 2026 | Landsman Stephen N | EVP, General Counsel | M | Restricted Stock Units | 3228 | $72.57 | 21,616.0000 | 257,000,000 | 12.99% | 0.00% |
| April 1, 2026 | DeVeau Michael | EVP, CFO | M | Common Stock | 4735 | $0.00 | 15,330.5720 | 257,000,000 | 44.69% | 0.00% |
| April 1, 2026 | DeVeau Michael | EVP, CFO | F | Common Stock | 2418 | $72.57 | 12,912.5720 | 257,000,000 | 15.77% | 0.00% |
| April 1, 2026 | DeVeau Michael | EVP, CFO | A | Restricted Stock Units | 16536 | $0.00 | 26,476.0000 | 257,000,000 | 166.36% | 0.01% |
| April 1, 2026 | DeVeau Michael | EVP, CFO | M | Restricted Stock Units | 4735 | $72.57 | 21,741.0000 | 257,000,000 | 17.88% | 0.00% |
| April 1, 2026 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 2583 | $0.00 | 5,342.0000 | 257,000,000 | 93.62% | 0.00% |
| April 1, 2026 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 932 | $72.57 | 4,410.0000 | 257,000,000 | 17.45% | 0.00% |
| April 1, 2026 | Teles de Mendonca Ana Paula | President, Scent | A | Restricted Stock Units | 12402 | $0.00 | 24,034.0000 | 257,000,000 | 106.62% | 0.00% |
| April 1, 2026 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 2583 | $72.57 | 21,451.0000 | 257,000,000 | 10.75% | 0.00% |
| Aug. 4, 2023 | Costa Mark J | Director | P | Common Stock | 15 | $80.95 | 478.0000 | 255,000,000 | 3.24% | 0.00% |
| Oct. 25, 2023 | Costa Mark J | Director | S | Common Stock | 15 | $66.05 | 463.0000 | 255,000,000 | 3.14% | 0.00% |
| May 30, 2023 | Costa Mark J | Director | S | Common Stock | 15 | $77.49 | 463.0000 | 255,000,000 | 3.14% | 0.00% |
| March 24, 2023 | Costa Mark J | Director | P | Common Stock | 10 | $84.27 | 10.0000 | 255,000,000 | 9999.99% | 0.00% |
| March 6, 2026 | FRIBOURG PAUL J | Director | P | Common Stock | 3 | $73.93 | 2,452,839.0000 | 257,000,000 | 0.00% | 0.00% |
| March 13, 2026 | Fyrwald J Erik | Chief Executive Officer | P | Common Stock | 13360 | $69.85 | 102,920.0000 | 257,000,000 | 14.92% | 0.01% |
| Sept. 29, 2025 | FRIBOURG PAUL J | Director | S | Common Stock | 7 | $60.87 | 2,452,800.0000 | 256,000,000 | 0.00% | 0.00% |
| Oct. 30, 2025 | FRIBOURG PAUL J | Director | P | Common Stock | 39 | $63.64 | 2,452,839.0000 | 257,000,000 | 0.00% | 0.00% |
| Aug. 27, 2025 | FRIBOURG PAUL J | Director | P | Common Stock | 71 | $66.91 | 2,452,880.0000 | 256,000,000 | 0.00% | 0.00% |
| Nov. 18, 2025 | FRIBOURG PAUL J | Director | S | Common Stock | 187 | $65.42 | 2,452,693.0000 | 257,000,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | FRIBOURG PAUL J | Director | P | Common Stock | 146 | $74.63 | 2,452,839.0000 | 257,000,000 | 0.01% | 0.00% |
| Dec. 10, 2025 | FRIBOURG PAUL J | Director | S | Common Stock | 25 | $65.27 | 2,452,839.0000 | 257,000,000 | 0.00% | 0.00% |
| Dec. 15, 2025 | FRIBOURG PAUL J | Director | S | Common Stock | 3 | $63.35 | 2,452,836.0000 | 257,000,000 | 0.00% | 0.00% |
| March 12, 2026 | FRIBOURG PAUL J | Director | P | Common Stock | 14200 | $70.07 | 2,452,839.0000 | 257,000,000 | 0.58% | 0.01% |
| March 12, 2026 | Fyrwald J Erik | Chief Executive Officer | P | Common Stock | 900 | $68.87 | 89,560.0000 | 257,000,000 | 1.02% | 0.00% |
| March 12, 2026 | FRIBOURG PAUL J | Director | P | Common Stock | 142000 | $70.13 | 2,452,839.0000 | 257,000,000 | 6.14% | 0.06% |
| Jan. 2, 2026 | Muller Andres Roberto | President, Food Ingredients | F | Common Stock | 633 | $68.03 | 1,192.0000 | 257,000,000 | 34.68% | 0.00% |
| Jan. 2, 2026 | Muller Andres Roberto | President, Food Ingredients | M | Common Stock | 1825 | $0.00 | 1,825.0000 | 257,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | Muller Andres Roberto | President, Food Ingredients | M | Restricted Stock Units | 1825 | $68.03 | 11,400.0000 | 257,000,000 | 13.80% | 0.00% |
| Dec. 12, 2025 | Landsman Stephen N | EVP, General Counsel | P | Common Stock | 3100 | $63.48 | 15,100.0000 | 257,000,000 | 25.83% | 0.00% |
| Dec. 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 10774 | $0.00 | 20,073.0000 | 257,000,000 | 115.86% | 0.00% |
| Dec. 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 10774 | $69.27 | 11,752.0000 | 257,000,000 | 47.83% | 0.00% |
| Dec. 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 5214 | $69.27 | 14,859.0000 | 257,000,000 | 25.98% | 0.00% |
| Nov. 11, 2025 | ICAHN BRETT | Director | A | Common Stock | 13000 | $64.44 | 33,000.0000 | 257,000,000 | 65.00% | 0.01% |
| Nov. 10, 2025 | ICAHN BRETT | Director | A | Common Stock | 20000 | $62.96 | 20,000.0000 | 257,000,000 | 9999.99% | 0.01% |
| Nov. 7, 2025 | O'Byrne Kevin | Director | A | Common Stock | 2000 | $62.09 | 22,946.0000 | 257,000,000 | 9.55% | 0.00% |
| Nov. 6, 2025 | O'Byrne Kevin | Director | A | Common Stock | 1500 | $62.91 | 17,696.0000 | 257,000,000 | 9.26% | 0.00% |
| Nov. 7, 2025 | O'Byrne Kevin | Director | A | Common Stock | 5250 | $62.46 | 22,946.0000 | 257,000,000 | 29.67% | 0.00% |
| Nov. 3, 2025 | ICAHN BRETT | Director | A | Restricted Stock Units | 1712 | $0.00 | 1,712.0000 | 257,000,000 | 9999.99% | 0.00% |
| Nov. 3, 2025 | Mulligan Richard | Director | A | Restricted Stock Units | 1712 | $0.00 | 1,712.0000 | 257,000,000 | 9999.99% | 0.00% |
| Sept. 2, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Restricted Stock Units | 11506 | $0.00 | 14,926.0000 | 256,000,000 | 43.53% | 0.00% |
| Sept. 2, 2025 | Mantas Jesus B | Director | A | Restricted Stock Units | 2281 | $0.00 | 2,281.0000 | 256,000,000 | 9999.99% | 0.00% |
| Sept. 2, 2025 | FRIBOURG PAUL J | Director | A | Restricted Stock Units | 2281 | $0.00 | 2,281.0000 | 256,000,000 | 9999.99% | 0.00% |
| Sept. 2, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Common Stock | 11506 | $0.00 | 38,986.0000 | 256,000,000 | 41.87% | 0.00% |
| Sept. 2, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Common Stock | 2302 | $0.00 | 41,288.0000 | 256,000,000 | 5.90% | 0.00% |
| Sept. 2, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 1176 | $66.55 | 40,112.0000 | 256,000,000 | 2.85% | 0.00% |
| Sept. 2, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 5874 | $66.55 | 34,238.0000 | 256,000,000 | 14.64% | 0.00% |
| Sept. 2, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Restricted Stock Units | 2302 | $0.00 | 26,432.0000 | 256,000,000 | 8.01% | 0.00% |
| Aug. 7, 2025 | FRIBOURG PAUL J | Director | P | Common Stock | 15450 | $64.80 | 2,296,180.0000 | 256,000,000 | 0.68% | 0.01% |
| Aug. 7, 2025 | Fyrwald J Erik | Chief Executive Officer | P | Common Stock | 15300 | $64.95 | 88,660.0000 | 256,000,000 | 20.86% | 0.01% |
| July 1, 2025 | Drosos Virginia | Director | A | Restricted Stock Units | 2335 | $0.00 | 2,335.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 5, 2025 | Arora Yuvraj | President, Taste & CCO | M | Restricted Stock Units | 17309 | $79.15 | 20,059.0000 | 256,000,000 | 46.32% | 0.01% |
| May 1, 2025 | Arora Yuvraj | President, Taste & CCO | M | Common Stock | 3572 | $0.00 | 6,810.0000 | 256,000,000 | 110.32% | 0.00% |
| June 2, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 643 | $0.00 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 5, 2025 | Arora Yuvraj | President, Taste & CCO | F | Common Stock | 8854 | $79.15 | 13,437.0000 | 256,000,000 | 39.72% | 0.00% |
| May 5, 2025 | Arora Yuvraj | President, Taste & CCO | M | Common Stock | 17309 | $0.00 | 22,291.0000 | 256,000,000 | 347.43% | 0.01% |
| June 2, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 643 | $0.00 | 3,088.0000 | 256,000,000 | 26.30% | 0.00% |
| June 2, 2025 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 329 | $75.71 | 2,759.0000 | 256,000,000 | 10.65% | 0.00% |
| May 1, 2025 | Arora Yuvraj | President, Taste & CCO | F | Common Stock | 1828 | $77.85 | 4,982.0000 | 256,000,000 | 26.84% | 0.00% |
| May 1, 2025 | Arora Yuvraj | President, Taste & CCO | M | Restricted Stock Units | 3572 | $77.85 | 37,368.0000 | 256,000,000 | 8.72% | 0.00% |
| May 22, 2025 | O'Byrne Kevin | Director | P | Common Stock | 4500 | $76.05 | 14,196.0000 | 256,000,000 | 46.41% | 0.00% |
| May 5, 2025 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 361 | $79.15 | 2,849.0000 | 256,000,000 | 11.25% | 0.00% |
| May 5, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 707 | $0.00 | 3,210.0000 | 256,000,000 | 28.25% | 0.00% |
| May 5, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 791 | $0.00 | 2,503.0000 | 256,000,000 | 46.20% | 0.00% |
| May 1, 2025 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 811 | $77.85 | 1,712.0000 | 256,000,000 | 32.14% | 0.00% |
| May 1, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 1587 | $0.00 | 2,523.0000 | 256,000,000 | 169.55% | 0.00% |
| May 5, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 791 | $0.00 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 5, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 707 | $0.00 | 11,632.0000 | 256,000,000 | 5.73% | 0.00% |
| May 1, 2025 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 1587 | $0.00 | 12,339.0000 | 256,000,000 | 11.40% | 0.00% |
| May 5, 2025 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 404 | $79.15 | 2,445.0000 | 256,000,000 | 14.18% | 0.00% |
| May 19, 2025 | Palau Hernandez Margarita | Director | P | Common Stock | 850 | $77.42 | 2,393.0000 | 256,000,000 | 55.09% | 0.00% |
| May 19, 2025 | Yildiz Beril | CAO, SVP & Controller | S | Common Stock | 2400 | $77.34 | 3,321.3700 | 256,000,000 | 41.95% | 0.00% |
| May 19, 2025 | Landsman Stephen N | EVP, General Counsel | P | Common Stock | 10000 | $77.22 | 10,000.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 19, 2025 | Landsman Stephen N | EVP, General Counsel | P | Common Stock | 2000 | $77.58 | 12,000.0000 | 256,000,000 | 20.00% | 0.00% |
| May 5, 2025 | DeVeau Michael | EVP, CFO | M | Common Stock | 884 | $0.00 | 11,047.5720 | 256,000,000 | 8.70% | 0.00% |
| May 1, 2025 | Yildiz Beril | CAO, SVP & Controller | M | Common Stock | 952 | $0.00 | 5,523.3700 | 256,000,000 | 20.83% | 0.00% |
| May 1, 2025 | Yildiz Beril | CAO, SVP & Controller | F | Common Stock | 344 | $77.85 | 5,179.3700 | 256,000,000 | 6.23% | 0.00% |
| May 5, 2025 | Yildiz Beril | CAO, SVP & Controller | M | Common Stock | 849 | $0.00 | 6,028.3700 | 256,000,000 | 16.39% | 0.00% |
| May 5, 2025 | Yildiz Beril | CAO, SVP & Controller | F | Common Stock | 307 | $79.15 | 5,721.3700 | 256,000,000 | 5.09% | 0.00% |
| May 1, 2025 | Yildiz Beril | CAO, SVP & Controller | M | Restricted Stock Units | 952 | $77.85 | 10,275.0000 | 256,000,000 | 8.48% | 0.00% |
| May 5, 2025 | Yildiz Beril | CAO, SVP & Controller | M | Restricted Stock Units | 849 | $79.15 | 9,426.0000 | 256,000,000 | 8.26% | 0.00% |
| May 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 1984 | $0.00 | 9,663.0000 | 256,000,000 | 25.84% | 0.00% |
| May 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 1013 | $77.85 | 8,650.0000 | 256,000,000 | 10.48% | 0.00% |
| May 5, 2025 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 1326 | $0.00 | 9,976.0000 | 256,000,000 | 15.33% | 0.00% |
| May 5, 2025 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 677 | $79.15 | 9,299.0000 | 256,000,000 | 6.79% | 0.00% |
| May 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 1984 | $77.85 | 23,852.0000 | 256,000,000 | 7.68% | 0.00% |
| May 5, 2025 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 1326 | $79.15 | 22,526.0000 | 256,000,000 | 5.56% | 0.00% |
| May 1, 2025 | DeVeau Michael | EVP, CFO | M | Common Stock | 1389 | $0.00 | 10,873.5720 | 256,000,000 | 14.64% | 0.00% |
| May 1, 2025 | DeVeau Michael | EVP, CFO | F | Common Stock | 710 | $77.85 | 10,163.5720 | 256,000,000 | 6.53% | 0.00% |
| May 5, 2025 | DeVeau Michael | EVP, CFO | F | Common Stock | 452 | $79.15 | 10,595.5720 | 256,000,000 | 4.09% | 0.00% |
| May 1, 2025 | DeVeau Michael | EVP, CFO | M | Restricted Stock Units | 1389 | $77.85 | 10,824.0000 | 256,000,000 | 11.37% | 0.00% |
| May 5, 2025 | DeVeau Michael | EVP, CFO | M | Restricted Stock Units | 884 | $79.15 | 9,940.0000 | 256,000,000 | 8.17% | 0.00% |
| May 1, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Common Stock | 2381 | $0.00 | 27,817.0000 | 256,000,000 | 9.36% | 0.00% |
| May 1, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 1202 | $77.85 | 26,615.0000 | 256,000,000 | 4.32% | 0.00% |
| May 5, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Common Stock | 1768 | $0.00 | 28,383.0000 | 256,000,000 | 6.64% | 0.00% |
| May 5, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 903 | $79.15 | 27,480.0000 | 256,000,000 | 3.18% | 0.00% |
| May 1, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Restricted Stock Units | 2381 | $77.85 | 30,502.0000 | 256,000,000 | 7.24% | 0.00% |
| May 5, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Restricted Stock Units | 1768 | $79.15 | 28,734.0000 | 256,000,000 | 5.80% | 0.00% |
| May 1, 2025 | Palau Hernandez Margarita | Director | M | Common Stock | 1543 | $0.00 | 1,543.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Palau Hernandez Margarita | Director | M | Restricted Stock Units | 1543 | $77.85 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 1, 2025 | Palau Hernandez Margarita | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | O'Byrne Kevin | Director | M | Common Stock | 1875 | $0.00 | 10,090.0000 | 256,000,000 | 22.82% | 0.00% |
| May 1, 2025 | O'Byrne Kevin | Director | F | Common Stock | 394 | $77.85 | 9,696.0000 | 256,000,000 | 3.90% | 0.00% |
| May 1, 2025 | O'Byrne Kevin | Director | M | Restricted Stock Units | 1875 | $77.85 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 1, 2025 | O'Byrne Kevin | Director | A | Restricted Stock Units | 4282 | $0.00 | 4,282.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 15, 2025 | Khan Mehmood | Director | P | Common Stock | 300 | $75.32 | 4,604.0000 | 256,000,000 | 6.97% | 0.00% |
| May 15, 2025 | Khan Mehmood | Director | P | Common Stock | 3700 | $75.33 | 4,304.0000 | 256,000,000 | 612.58% | 0.00% |
| May 8, 2025 | Fyrwald J Erik | Chief Executive Officer | P | Common Stock | 700 | $74.00 | 49,060.0000 | 256,000,000 | 1.45% | 0.00% |
| May 9, 2025 | Fyrwald J Erik | Chief Executive Officer | P | Common Stock | 24300 | $73.97 | 73,360.0000 | 256,000,000 | 49.53% | 0.01% |
| May 1, 2025 | JAMISON CYNTHIA T | Director | M | Restricted Stock Units | 604 | $77.85 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 1, 2025 | JAMISON CYNTHIA T | Director | M | Common Stock | 604 | $0.00 | 604.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Willoughby Dawn C | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Boor Kathryn Jean | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Ferraro John Francis | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Fyrwald J Erik | Chief Executive Officer | M | Restricted Stock Units | 15875 | $77.85 | 88,059.0000 | 256,000,000 | 15.27% | 0.01% |
| May 1, 2025 | Fyrwald J Erik | Chief Executive Officer | F | Common Stock | 8105 | $77.85 | 48,360.0000 | 256,000,000 | 14.35% | 0.00% |
| May 1, 2025 | Fyrwald J Erik | Chief Executive Officer | M | Common Stock | 15875 | $0.00 | 56,465.0000 | 256,000,000 | 39.11% | 0.01% |
| May 1, 2025 | Khan Mehmood | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Khan Mehmood | Director | M | Restricted Stock Units | 604 | $77.85 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 1, 2025 | Khan Mehmood | Director | M | Common Stock | 604 | $0.00 | 604.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Costa Mark J | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Costa Mark J | Director | M | Restricted Stock Units | 1875 | $77.85 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 1, 2025 | INTRIERI VINCENT J | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | Costa Mark J | Director | M | Common Stock | 1875 | $0.00 | 4,014.0000 | 256,000,000 | 87.66% | 0.00% |
| May 1, 2025 | INTRIERI VINCENT J | Director | M | Restricted Stock Units | 604 | $77.85 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| May 1, 2025 | INTRIERI VINCENT J | Director | M | Common Stock | 604 | $0.00 | 604.0000 | 256,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | JAMISON CYNTHIA T | Director | A | Restricted Stock Units | 2569 | $0.00 | 2,569.0000 | 256,000,000 | 9999.99% | 0.00% |
| April 4, 2025 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 230 | $73.12 | 10,132.0000 | 256,000,000 | 2.22% | 0.00% |
| April 4, 2025 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 579 | $73.12 | 9,553.0000 | 256,000,000 | 5.71% | 0.00% |
| April 4, 2025 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 503 | $0.00 | 6,206.0000 | 256,000,000 | 7.50% | 0.00% |
| April 4, 2025 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 1258 | $0.00 | 0.0000 | 256,000,000 | 100.00% | 0.00% |
| April 4, 2025 | DeVeau Michael | CFO | M | Common Stock | 1281 | $0.00 | 9,491.5720 | 256,000,000 | 15.60% | 0.00% |
| April 4, 2025 | DeVeau Michael | CFO | M | Common Stock | 712 | $0.00 | 10,203.5720 | 256,000,000 | 7.50% | 0.00% |
| April 4, 2025 | DeVeau Michael | CFO | F | Common Stock | 257 | $73.12 | 9,946.5720 | 256,000,000 | 2.52% | 0.00% |
| April 4, 2025 | DeVeau Michael | CFO | F | Common Stock | 462 | $73.12 | 9,484.5720 | 256,000,000 | 4.64% | 0.00% |
| April 4, 2025 | DeVeau Michael | CFO | M | Restricted Stock Units | 712 | $0.00 | 13,494.0000 | 256,000,000 | 5.01% | 0.00% |
| April 4, 2025 | DeVeau Michael | CFO | M | Restricted Stock Units | 1281 | $0.00 | 12,213.0000 | 256,000,000 | 9.49% | 0.00% |
| April 4, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Common Stock | 4602 | $0.00 | 27,981.0000 | 256,000,000 | 19.68% | 0.00% |
| April 4, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 2545 | $73.12 | 25,436.0000 | 256,000,000 | 9.10% | 0.00% |
| April 4, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | M | Restricted Stock Units | 4602 | $0.00 | 32,883.0000 | 256,000,000 | 12.28% | 0.00% |
| April 4, 2025 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 1258 | $0.00 | 9,859.0000 | 256,000,000 | 14.63% | 0.00% |
| April 4, 2025 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 503 | $0.00 | 10,362.0000 | 256,000,000 | 5.10% | 0.00% |
| April 1, 2025 | Teles de Mendonca Ana Paula | President, Scent | A | Restricted Stock Units | 7749 | $0.00 | 13,926.0000 | 256,000,000 | 125.45% | 0.00% |
| April 1, 2025 | DeVeau Michael | CFO | A | Restricted Stock Units | 14206 | $0.00 | 14,206.0000 | 256,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | Finzel Ralf | EVP, Global Operations Officer | A | Restricted Stock Units | 6457 | $0.00 | 25,836.0000 | 256,000,000 | 33.32% | 0.00% |
| April 1, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | A | Restricted Stock Units | 8395 | $0.00 | 37,485.0000 | 256,000,000 | 28.86% | 0.00% |
| April 1, 2025 | Landsman Stephen N | EVP, General Counsel | A | Restricted Stock Units | 9686 | $0.00 | 9,686.0000 | 256,000,000 | 9999.99% | 0.00% |
| April 1, 2025 | Yildiz Beril | CAO, SVP & Controller | A | Restricted Stock Units | 3100 | $0.00 | 11,227.0000 | 256,000,000 | 38.14% | 0.00% |
| April 1, 2025 | Fyrwald J Erik | CEO | A | Restricted Stock Units | 56309 | $0.00 | 103,934.0000 | 256,000,000 | 118.23% | 0.02% |
| April 1, 2025 | Muller Andres Roberto | President, Food Ingredients | A | Restricted Stock Units | 7749 | $0.00 | 13,225.0000 | 256,000,000 | 141.51% | 0.00% |
| April 1, 2025 | Lourenco Leticia Goncalves | President, Health & Bioscience | A | Restricted Stock Units | 21955 | $0.00 | 21,955.0000 | 256,000,000 | 9999.99% | 0.01% |
| April 1, 2025 | Arora Yuvraj | President, Taste&CCO | A | Restricted Stock Units | 12915 | $0.00 | 40,940.0000 | 256,000,000 | 46.08% | 0.01% |
| March 4, 2025 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 34 | $79.79 | 8,601.0000 | 256,000,000 | 0.39% | 0.00% |
| March 4, 2025 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 77 | $79.79 | 7,280.0000 | 256,000,000 | 1.05% | 0.00% |
| March 4, 2025 | Herriott Simon | Pres. Health & Bioscience | A | Common Stock | 237 | $0.00 | 10,841.3240 | 256,000,000 | 2.23% | 0.00% |
| March 5, 2025 | O'Byrne Kevin | Director | P | Common Stock | 6500 | $80.44 | 8,215.0000 | 256,000,000 | 379.01% | 0.00% |
| March 4, 2025 | DeVeau Michael | CFO | F | Common Stock | 42 | $79.79 | 8,210.5720 | 256,000,000 | 0.51% | 0.00% |
| March 4, 2025 | DeVeau Michael | CFO | A | Common Stock | 101 | $0.00 | 8,252.5720 | 256,000,000 | 1.24% | 0.00% |
| March 4, 2025 | Herriott Simon | Pres. Health & Bioscience | F | Common Stock | 86 | $79.79 | 10,755.3240 | 256,000,000 | 0.79% | 0.00% |
| March 4, 2025 | Johnson Jennifer Amy | EVP, General Counsel | A | Common Stock | 186 | $0.00 | 7,357.0000 | 256,000,000 | 2.59% | 0.00% |
| March 4, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | A | Common Stock | 269 | $0.00 | 23,502.0000 | 256,000,000 | 1.16% | 0.00% |
| March 4, 2025 | Borg Deborah | EVP, Chief Ppl&Culture Officer | F | Common Stock | 123 | $79.79 | 23,379.0000 | 256,000,000 | 0.52% | 0.00% |
| March 4, 2025 | Teles de Mendonca Ana Paula | President, Scent | A | Common Stock | 35 | $0.00 | 951.0000 | 256,000,000 | 3.82% | 0.00% |
| March 4, 2025 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 15 | $79.79 | 936.0000 | 256,000,000 | 1.58% | 0.00% |
| March 4, 2025 | Strzelecki Angela | President, Pharma Solutions | A | Common Stock | 96 | $0.00 | 8,635.0000 | 256,000,000 | 1.12% | 0.00% |
| March 4, 2025 | Fyrwald J Erik | CEO | P | Common Stock | 25000 | $80.24 | 40,590.0000 | 256,000,000 | 160.36% | 0.01% |
| Feb. 3, 2025 | INTRIERI VINCENT J | Director | A | Restricted Stock Units | 604 | $0.00 | 604.0000 | 256,000,000 | 9999.99% | 0.00% |
| Feb. 3, 2025 | JAMISON CYNTHIA T | Director | A | Restricted Stock Units | 604 | $0.00 | 604.0000 | 256,000,000 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Khan Mehmood | Director | A | Restricted Stock Units | 604 | $0.00 | 604.0000 | 256,000,000 | 9999.99% | 0.00% |
| Jan. 15, 2025 | Yildiz Beril | CAO, SVP & Controller | F | Common Stock | 1340 | $84.17 | 4,571.3700 | 256,000,000 | 22.67% | 0.00% |
| Jan. 15, 2025 | Yildiz Beril | CAO, SVP & Controller | A | Common Stock | 3976 | $0.00 | 5,911.3700 | 256,000,000 | 205.47% | 0.00% |
| Jan. 2, 2025 | Muller Andres Roberto | President, Food Ingredients | A | Restricted Stock Units | 5476 | $0.00 | 5,476.0000 | 256,000,000 | 9999.99% | 0.00% |
| Dec. 2, 2024 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 5387 | $0.00 | 9,622.0000 | 257,000,000 | 127.20% | 0.00% |
| Dec. 2, 2024 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 5387 | $0.00 | 19,379.0000 | 257,000,000 | 21.75% | 0.00% |
| Dec. 2, 2024 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 1943 | $91.27 | 7,679.0000 | 257,000,000 | 20.19% | 0.00% |
| Nov. 11, 2024 | Arora Yuvraj | President, Nourish | S | Common Stock | 5000 | $91.76 | 3,238.0000 | 257,000,000 | 60.69% | 0.00% |
| Oct. 3, 2024 | Yildiz Beril | CAO, SVP & Controller | M | Common Stock | 1078 | $0.00 | 2,324.2010 | 257,000,000 | 86.50% | 0.00% |
| Oct. 3, 2024 | Yildiz Beril | CAO, SVP & Controller | F | Common Stock | 389 | $100.63 | 1,935.2010 | 257,000,000 | 16.74% | 0.00% |
| Oct. 3, 2024 | Yildiz Beril | CAO, SVP & Controller | M | Restricted Stock Units | 1078 | $0.00 | 8,127.0000 | 257,000,000 | 11.71% | 0.00% |
| Oct. 1, 2024 | RICHTER GLENN R | CFO | M | Common Stock | 11812 | $0.00 | 32,171.0000 | 257,000,000 | 58.02% | 0.00% |
| Oct. 1, 2024 | RICHTER GLENN R | CFO | M | Restricted Stock Units | 11812 | $0.00 | 20,392.0000 | 257,000,000 | 36.68% | 0.00% |
| Oct. 1, 2024 | RICHTER GLENN R | CFO | F | Common Stock | 5122 | $103.12 | 27,049.0000 | 257,000,000 | 15.92% | 0.00% |
| Sept. 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | F | Common Stock | 5874 | $103.58 | 23,233.0000 | 255,000,000 | 20.18% | 0.00% |
| Sept. 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | F | Common Stock | 1175 | $103.58 | 29,107.0000 | 255,000,000 | 3.88% | 0.00% |
| Sept. 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Common Stock | 11506 | $0.00 | 27,981.0000 | 255,000,000 | 69.84% | 0.00% |
| Sept. 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Common Stock | 2301 | $0.00 | 30,282.0000 | 255,000,000 | 8.22% | 0.00% |
| Sept. 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Restricted Stock Units | 11506 | $0.00 | 29,090.0000 | 255,000,000 | 28.34% | 0.00% |
| Sept. 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Restricted Stock Units | 2301 | $0.00 | 40,596.0000 | 255,000,000 | 5.36% | 0.00% |
| July 3, 2024 | Herriott Simon | Pres. Health & Bioscience | M | Restricted Stock Units | 627 | $0.00 | 12,123.0000 | 255,000,000 | 4.92% | 0.00% |
| July 3, 2024 | Herriott Simon | Pres. Health & Bioscience | F | Common Stock | 289 | $95.02 | 10,470.2570 | 255,000,000 | 2.69% | 0.00% |
| July 3, 2024 | Herriott Simon | Pres. Health & Bioscience | M | Common Stock | 627 | $0.00 | 10,759.2570 | 255,000,000 | 6.19% | 0.00% |
| July 1, 2024 | Palau Hernandez Margarita | Director | A | Restricted Stock Units | 1543 | $0.00 | 1,543.0000 | 255,000,000 | 9999.99% | 0.00% |
| June 13, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 2588 | $77.16 | 11,127.0000 | 255,000,000 | 30.31% | 0.00% |
| June 13, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Stock Options (right to buy) | 2588 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| June 13, 2024 | Strzelecki Angela | President, Pharma Solutions | S | Common Stock | 2588 | $95.66 | 8,539.0000 | 255,000,000 | 23.26% | 0.00% |
| May 6, 2024 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 726 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Yildiz Beril | CAO, SVP & Controller | M | Common Stock | 848 | $0.00 | 1,588.2010 | 255,000,000 | 114.56% | 0.00% |
| May 3, 2024 | Yildiz Beril | CAO, SVP & Controller | F | Common Stock | 342 | $86.64 | 1,246.2010 | 255,000,000 | 21.53% | 0.00% |
| May 3, 2024 | Yildiz Beril | CAO, SVP & Controller | M | Restricted Stock Units | 848 | $0.00 | 9,205.0000 | 255,000,000 | 8.44% | 0.00% |
| May 3, 2024 | O'Byrne Kevin | Director | M | Common Stock | 1671 | $0.00 | 1,933.0000 | 255,000,000 | 637.79% | 0.00% |
| May 3, 2024 | O'Byrne Kevin | Director | F | Common Stock | 218 | $86.64 | 1,715.0000 | 255,000,000 | 11.28% | 0.00% |
| May 3, 2024 | O'Byrne Kevin | Director | M | Restricted Stock Units | 1671 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 1060 | $0.00 | 8,868.0000 | 255,000,000 | 13.58% | 0.00% |
| May 3, 2024 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 329 | $86.64 | 8,539.0000 | 255,000,000 | 3.71% | 0.00% |
| May 3, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 1060 | $0.00 | 6,709.0000 | 255,000,000 | 13.64% | 0.00% |
| May 3, 2024 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 707 | $0.00 | 707.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 3, 2024 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 255 | $86.64 | 452.0000 | 255,000,000 | 36.07% | 0.00% |
| May 6, 2024 | Teles de Mendonca Ana Paula | President, Scent | M | Common Stock | 726 | $0.00 | 1,178.0000 | 255,000,000 | 160.62% | 0.00% |
| May 6, 2024 | Teles de Mendonca Ana Paula | President, Scent | F | Common Stock | 262 | $88.66 | 916.0000 | 255,000,000 | 22.24% | 0.00% |
| May 3, 2024 | Teles de Mendonca Ana Paula | President, Scent | M | Restricted Stock Units | 707 | $0.00 | 6,177.0000 | 255,000,000 | 10.27% | 0.00% |
| May 3, 2024 | RICHTER GLENN R | CFO | M | Common Stock | 4243 | $0.00 | 21,889.0000 | 255,000,000 | 24.05% | 0.00% |
| May 3, 2024 | RICHTER GLENN R | CFO | F | Common Stock | 1530 | $86.64 | 20,359.0000 | 255,000,000 | 6.99% | 0.00% |
| May 3, 2024 | RICHTER GLENN R | CFO | M | Restricted Stock Units | 4243 | $0.00 | 32,204.0000 | 255,000,000 | 11.64% | 0.00% |
| May 3, 2024 | Johnson Jennifer Amy | EVP, General Counsel | M | Common Stock | 2121 | $0.00 | 7,936.0000 | 255,000,000 | 36.47% | 0.00% |
| May 3, 2024 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 765 | $86.64 | 7,171.0000 | 255,000,000 | 9.64% | 0.00% |
| May 3, 2024 | Johnson Jennifer Amy | EVP, General Counsel | M | Restricted Stock Units | 2121 | $0.00 | 11,956.0000 | 255,000,000 | 15.07% | 0.00% |
| May 3, 2024 | Hu Gaoxiang | Director | M | Common Stock | 1671 | $0.00 | 2,105.0000 | 255,000,000 | 385.02% | 0.00% |
| May 3, 2024 | Hu Gaoxiang | Director | M | Restricted Stock Units | 1671 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Herriott Simon | Pres. Health & Bioscience | M | Common Stock | 1591 | $0.00 | 10,625.2570 | 255,000,000 | 17.61% | 0.00% |
| May 3, 2024 | Herriott Simon | Pres. Health & Bioscience | F | Common Stock | 493 | $86.64 | 10,132.2570 | 255,000,000 | 4.64% | 0.00% |
| May 3, 2024 | Herriott Simon | Pres. Health & Bioscience | M | Restricted Stock Units | 1591 | $0.00 | 12,750.0000 | 255,000,000 | 11.09% | 0.00% |
| May 3, 2024 | Gold Christina A | Director | M | Common Stock | 1671 | $0.00 | 10,840.0000 | 255,000,000 | 18.22% | 0.00% |
| May 3, 2024 | Gold Christina A | Director | M | Restricted Stock Units | 1671 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 1326 | $0.00 | 4,770.0000 | 255,000,000 | 38.50% | 0.00% |
| May 3, 2024 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 535 | $86.64 | 4,235.0000 | 255,000,000 | 11.22% | 0.00% |
| May 3, 2024 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 1326 | $0.00 | 24,766.0000 | 255,000,000 | 5.08% | 0.00% |
| May 3, 2024 | Ferguson Roger W. Jr. | Director | M | Common Stock | 2625 | $0.00 | 2,625.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 3, 2024 | Ferguson Roger W. Jr. | Director | M | Restricted Stock Units | 2625 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | DAVIDSON CAROL ANTHONY | Director | M | Common Stock | 1671 | $0.00 | 1,926.0000 | 255,000,000 | 655.29% | 0.00% |
| May 3, 2024 | DAVIDSON CAROL ANTHONY | Director | M | Restricted Stock Units | 1671 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Costa Mark J | Director | M | Common Stock | 1671 | $0.00 | 2,139.0000 | 255,000,000 | 357.05% | 0.00% |
| May 3, 2024 | Costa Mark J | Director | M | Restricted Stock Units | 1671 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Bruno Barry A. | Director | M | Common Stock | 1671 | $0.00 | 3,205.0000 | 255,000,000 | 108.93% | 0.00% |
| May 3, 2024 | Bruno Barry A. | Director | M | Restricted Stock Units | 1671 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Common Stock | 1768 | $0.00 | 17,188.0000 | 255,000,000 | 11.47% | 0.00% |
| May 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | F | Common Stock | 713 | $86.64 | 16,475.0000 | 255,000,000 | 4.15% | 0.00% |
| May 3, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Restricted Stock Units | 1768 | $0.00 | 42,897.0000 | 255,000,000 | 3.96% | 0.00% |
| May 3, 2024 | Arora Yuvraj | President, Nourish | M | Common Stock | 11538 | $0.00 | 11,538.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 3, 2024 | Arora Yuvraj | President, Nourish | F | Common Stock | 3300 | $86.64 | 8,238.0000 | 255,000,000 | 28.60% | 0.00% |
| May 3, 2024 | Arora Yuvraj | President, Nourish | M | Restricted Stock Units | 11538 | $0.00 | 28,025.0000 | 255,000,000 | 29.16% | 0.00% |
| May 1, 2024 | Strzelecki Angela | President, Pharma Solutions | A | Restricted Stock Units | 5209 | $0.00 | 7,769.0000 | 255,000,000 | 203.48% | 0.00% |
| May 1, 2024 | Arora Yuvraj | President, Nourish | A | Restricted Stock Units | 10716 | $0.00 | 39,563.0000 | 255,000,000 | 37.15% | 0.00% |
| May 1, 2024 | Ferguson Roger W. Jr. | Director | A | Restricted Stock Units | 2947 | $0.00 | 2,947.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Willoughby Dawn C | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | O'Byrne Kevin | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Hu Gaoxiang | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Gold Christina A | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Ferraro John Francis | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | DAVIDSON CAROL ANTHONY | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Costa Mark J | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Boor Kathryn Jean | Director | A | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | Teles de Mendonca Ana Paula | President, Scent | A | Restricted Stock Units | 4762 | $0.00 | 6,884.0000 | 255,000,000 | 224.41% | 0.00% |
| May 1, 2024 | Yildiz Beril | CAO, SVP & Controller | A | Restricted Stock Units | 3572 | $0.00 | 7,196.0000 | 255,000,000 | 98.57% | 0.00% |
| May 1, 2024 | Yildiz Beril | CAO, SVP & Controller | A | Restricted Stock Units | 2857 | $0.00 | 10,053.0000 | 255,000,000 | 39.70% | 0.00% |
| May 1, 2024 | Fyrwald J Erik | CEO | A | Restricted Stock Units | 47625 | $0.00 | 47,625.0000 | 255,000,000 | 9999.99% | 0.02% |
| May 1, 2024 | Finzel Ralf | EVP, Global Operations Officer | A | Restricted Stock Units | 5953 | $0.00 | 26,092.0000 | 255,000,000 | 29.56% | 0.00% |
| May 1, 2024 | Johnson Jennifer Amy | EVP, General Counsel | A | Restricted Stock Units | 8334 | $0.00 | 14,077.0000 | 255,000,000 | 145.12% | 0.00% |
| May 1, 2024 | Borg Deborah | EVP, Chief HR and D&I Officer | A | Restricted Stock Units | 7144 | $0.00 | 44,665.0000 | 255,000,000 | 19.04% | 0.00% |
| May 1, 2024 | Herriott Simon | Pres. Health & Bioscience | A | Restricted Stock Units | 8930 | $0.00 | 14,341.0000 | 255,000,000 | 165.03% | 0.00% |
| May 1, 2024 | RICHTER GLENN R | CFO | A | Restricted Stock Units | 11906 | $0.00 | 36,447.0000 | 255,000,000 | 48.51% | 0.00% |
| April 5, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 518 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| April 5, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 622 | $0.00 | 2,560.0000 | 255,000,000 | 19.55% | 0.00% |
| April 5, 2024 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 193 | $83.34 | 7,808.0000 | 255,000,000 | 2.41% | 0.00% |
| April 5, 2024 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 161 | $83.34 | 8,001.0000 | 255,000,000 | 1.97% | 0.00% |
| April 5, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 518 | $0.00 | 8,162.0000 | 255,000,000 | 6.78% | 0.00% |
| April 5, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 622 | $0.00 | 7,644.0000 | 255,000,000 | 8.86% | 0.00% |
| April 5, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | M | Restricted Stock Units | 346 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| April 5, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | M | Restricted Stock Units | 1244 | $0.00 | 5,411.0000 | 255,000,000 | 18.69% | 0.00% |
| April 5, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | F | Common Stock | 386 | $83.34 | 9,001.5710 | 255,000,000 | 4.11% | 0.00% |
| April 5, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | F | Common Stock | 108 | $83.34 | 9,387.5710 | 255,000,000 | 1.14% | 0.00% |
| April 5, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | M | Common Stock | 346 | $0.00 | 9,495.5710 | 255,000,000 | 3.78% | 0.00% |
| April 5, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | M | Common Stock | 1244 | $0.00 | 9,149.5710 | 255,000,000 | 15.74% | 0.00% |
| April 5, 2024 | Johnson Jennifer Amy | EVP, General Counsel | M | Restricted Stock Units | 346 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| April 5, 2024 | Johnson Jennifer Amy | EVP, General Counsel | M | Restricted Stock Units | 622 | $0.00 | 5,743.0000 | 255,000,000 | 9.77% | 0.00% |
| April 5, 2024 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 225 | $83.34 | 5,815.0000 | 255,000,000 | 3.73% | 0.00% |
| April 5, 2024 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 125 | $83.34 | 6,040.0000 | 255,000,000 | 2.03% | 0.00% |
| April 5, 2024 | Johnson Jennifer Amy | EVP, General Counsel | M | Common Stock | 346 | $0.00 | 6,165.0000 | 255,000,000 | 5.95% | 0.00% |
| April 5, 2024 | Johnson Jennifer Amy | EVP, General Counsel | M | Common Stock | 622 | $0.00 | 5,819.0000 | 255,000,000 | 11.97% | 0.00% |
| April 1, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | F | Common Stock | 461 | $86.37 | 7,905.5710 | 255,000,000 | 5.51% | 0.00% |
| April 1, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | M | Common Stock | 1489 | $0.00 | 8,366.5710 | 255,000,000 | 21.65% | 0.00% |
| April 1, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | M | Restricted Stock Units | 1489 | $0.00 | 6,655.0000 | 255,000,000 | 18.28% | 0.00% |
| March 1, 2024 | Strzelecki Angela | President, Pharma Solutions | A | Common Stock | 130 | $0.00 | 7,070.0000 | 255,000,000 | 1.87% | 0.00% |
| March 1, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | A | Common Stock | 286 | $0.00 | 6,981.5710 | 255,000,000 | 4.27% | 0.00% |
| March 1, 2024 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 48 | $75.88 | 7,022.0000 | 255,000,000 | 0.68% | 0.00% |
| March 1, 2024 | Herriott Simon | Pres. Health & Biosci. & Scent | F | Common Stock | 104 | $75.88 | 6,877.5710 | 255,000,000 | 1.49% | 0.00% |
| March 1, 2024 | Clyburn Frank | Chief Executive Officer | M | Restricted Stock Units | 1324 | $0.00 | 33,682.0000 | 255,000,000 | 3.78% | 0.00% |
| March 1, 2024 | Clyburn Frank | Chief Executive Officer | F | Common Stock | 323 | $75.88 | 1,847.0000 | 255,000,000 | 14.88% | 0.00% |
| March 1, 2024 | Clyburn Frank | Chief Executive Officer | M | Common Stock | 1324 | $0.00 | 2,170.0000 | 255,000,000 | 156.50% | 0.00% |
| March 1, 2024 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 81 | $75.88 | 5,197.0000 | 255,000,000 | 1.53% | 0.00% |
| March 1, 2024 | RICHTER GLENN R | CFO | A | Common Stock | 99 | $0.00 | 17,692.0000 | 255,000,000 | 0.56% | 0.00% |
| March 1, 2024 | Johnson Jennifer Amy | EVP, General Counsel | A | Common Stock | 195 | $0.00 | 5,278.0000 | 255,000,000 | 3.84% | 0.00% |
| March 1, 2024 | RICHTER GLENN R | CFO | F | Common Stock | 46 | $75.88 | 17,646.0000 | 255,000,000 | 0.26% | 0.00% |
| March 1, 2024 | Fyrwald J Erik | CEO | A | Restricted Stock Units | 56250 | $0.00 | 56,250.0000 | 255,000,000 | 9999.99% | 0.02% |
| Jan. 3, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 1341 | $0.00 | 3,182.0000 | 255,000,000 | 29.65% | 0.00% |
| Jan. 3, 2024 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 478 | $79.99 | 6,940.0000 | 255,000,000 | 6.44% | 0.00% |
| Jan. 3, 2024 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 1341 | $0.00 | 7,418.0000 | 255,000,000 | 22.07% | 0.00% |
| Dec. 15, 2023 | Yildiz Beril | CAO, SVP & Controller | A | Common Stock | 52 | $79.62 | 740.2010 | 255,000,000 | 7.59% | 0.00% |
| Dec. 1, 2023 | Finzel Ralf | EVP, Global Operations Officer | M | Restricted Stock Units | 5387 | $0.00 | 20,139.0000 | 255,000,000 | 21.10% | 0.00% |
| Dec. 1, 2023 | Finzel Ralf | EVP, Global Operations Officer | M | Common Stock | 5387 | $0.00 | 5,387.0000 | 255,000,000 | 9999.99% | 0.00% |
| Dec. 1, 2023 | Finzel Ralf | EVP, Global Operations Officer | F | Common Stock | 1943 | $76.78 | 3,444.0000 | 255,000,000 | 36.07% | 0.00% |
| Nov. 1, 2023 | Johnson Jennifer Amy | EVP, General Counsel | M | Common Stock | 1041 | $0.00 | 5,459.0000 | 255,000,000 | 23.56% | 0.00% |
| Nov. 1, 2023 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 376 | $68.06 | 5,083.0000 | 255,000,000 | 6.89% | 0.00% |
| Nov. 1, 2023 | Johnson Jennifer Amy | EVP, General Counsel | M | Restricted Stock Units | 1041 | $0.00 | 6,365.0000 | 255,000,000 | 14.06% | 0.00% |
| Oct. 3, 2023 | Yildiz Beril | CAO, SVP & Controller | M | Restricted Stock Units | 1077 | $0.00 | 3,624.0000 | 255,000,000 | 22.91% | 0.00% |
| Oct. 3, 2023 | Yildiz Beril | CAO, SVP & Controller | F | Common Stock | 389 | $65.07 | 688.0000 | 255,000,000 | 36.12% | 0.00% |
| Oct. 3, 2023 | Yildiz Beril | CAO, SVP & Controller | M | Common Stock | 1077 | $0.00 | 1,077.0000 | 255,000,000 | 9999.99% | 0.00% |
| Oct. 2, 2023 | RICHTER GLENN R | CFO | F | Common Stock | 6031 | $65.97 | 17,593.0000 | 255,000,000 | 25.53% | 0.00% |
| Oct. 2, 2023 | RICHTER GLENN R | CFO | M | Restricted Stock Units | 11812 | $0.00 | 24,541.0000 | 255,000,000 | 32.49% | 0.00% |
| Oct. 2, 2023 | RICHTER GLENN R | CFO | M | Common Stock | 11812 | $0.00 | 23,624.0000 | 255,000,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | F | Common Stock | 9844 | $70.25 | 15,420.0000 | 255,000,000 | 38.96% | 0.00% |
| Sept. 1, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Common Stock | 23012 | $0.00 | 23,012.0000 | 255,000,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Common Stock | 4602 | $0.00 | 27,614.0000 | 255,000,000 | 20.00% | 0.00% |
| Sept. 1, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | F | Common Stock | 2350 | $70.25 | 25,264.0000 | 255,000,000 | 8.51% | 0.00% |
| Sept. 1, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Restricted Stock Units | 4602 | $0.00 | 60,533.0000 | 255,000,000 | 7.07% | 0.00% |
| Sept. 1, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | M | Restricted Stock Units | 23012 | $0.00 | 37,521.0000 | 255,000,000 | 38.02% | 0.01% |
| July 3, 2023 | Arora Yuvraj | President, Nourish | A | Restricted Stock Units | 28847 | $0.00 | 28,847.0000 | 255,000,000 | 9999.99% | 0.01% |
| July 3, 2023 | Herriott Simon | President Health & Biosciences | A | Restricted Stock Units | 1881 | $0.00 | 8,144.0000 | 255,000,000 | 30.03% | 0.00% |
| May 11, 2023 | Fauchon de Villeplee Christophe | President, Scent | S | Common Stock | 1972 | $86.35 | 9,093.0000 | 255,000,000 | 17.82% | 0.00% |
| May 4, 2023 | Costa Mark J | Director | M | Restricted Stock Units | 468 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Bruno Barry A. | Director | M | Restricted Stock Units | 1245 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Bruno Barry A. | Director | M | Common Stock | 1245 | $0.00 | 1,534.0000 | 255,000,000 | 430.80% | 0.00% |
| May 4, 2023 | Boor Kathryn Jean | Director | A | Stock Equivalent Unit | 1245 | $0.00 | 2,350.7930 | 255,000,000 | 112.59% | 0.00% |
| May 4, 2023 | Boor Kathryn Jean | Director | D | Restricted Stock Units | 1245 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | DAVIDSON CAROL ANTHONY | Director | A | Stock Equivalent Unit | 1245 | $0.00 | 2,350.7930 | 255,000,000 | 112.59% | 0.00% |
| May 4, 2023 | DAVIDSON CAROL ANTHONY | Director | D | Restricted Stock Units | 1245 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Ferguson Roger W. Jr. | Director | A | Stock Equivalent Unit | 1245 | $0.00 | 17,754.3860 | 255,000,000 | 7.54% | 0.00% |
| May 4, 2023 | Ferguson Roger W. Jr. | Director | D | Restricted Stock Units | 1245 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Ferraro John Francis | Director | A | Stock Equivalent Unit | 1245 | $0.00 | 8,609.7590 | 255,000,000 | 16.90% | 0.00% |
| May 4, 2023 | Ferraro John Francis | Director | D | Restricted Stock Units | 1245 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Gold Christina A | Director | M | Restricted Stock Units | 1245 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Gold Christina A | Director | M | Common Stock | 1245 | $0.00 | 9,169.0000 | 255,000,000 | 15.71% | 0.00% |
| May 4, 2023 | Hu Gaoxiang | Director | M | Restricted Stock Units | 434 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Hu Gaoxiang | Director | M | Common Stock | 434 | $0.00 | 434.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 4, 2023 | O'Byrne Kevin | Director | M | Restricted Stock Units | 262 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | O'Byrne Kevin | Director | M | Common Stock | 262 | $0.00 | 262.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 4, 2023 | Willoughby Dawn C | Director | M | Restricted Stock Units | 434 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| May 4, 2023 | Willoughby Dawn C | Director | M | Common Stock | 434 | $0.00 | 434.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Fauchon de Villeplee Christophe | President, Scent | A | Restricted Stock Units | 4774 | $0.00 | 4,774.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | RICHTER GLENN R | CFO | A | Restricted Stock Units | 12729 | $0.00 | 36,353.0000 | 255,000,000 | 53.88% | 0.00% |
| May 3, 2023 | Yildiz Beril | CAO, SVP & Controller | A | Restricted Stock Units | 2546 | $0.00 | 4,701.0000 | 255,000,000 | 118.14% | 0.00% |
| May 3, 2023 | Strzelecki Angela | President, Pharma Solutions | A | Restricted Stock Units | 3182 | $0.00 | 4,523.0000 | 255,000,000 | 237.29% | 0.00% |
| May 3, 2023 | Finzel Ralf | EVP, Global Operations Officer | A | Restricted Stock Units | 3978 | $0.00 | 25,526.0000 | 255,000,000 | 18.46% | 0.00% |
| May 3, 2023 | Borg Deborah | EVP, Chief HR and D&I Officer | A | Restricted Stock Units | 5304 | $0.00 | 65,135.0000 | 255,000,000 | 8.86% | 0.00% |
| May 3, 2023 | Clyburn Frank | Chief Executive Officer | A | Restricted Stock Units | 35006 | $0.00 | 35,006.0000 | 255,000,000 | 9999.99% | 0.01% |
| May 3, 2023 | Herriott Simon | President Health & Biosciences | A | Restricted Stock Units | 4774 | $0.00 | 6,263.0000 | 255,000,000 | 320.62% | 0.00% |
| May 3, 2023 | Johnson Jennifer Amy | EVP, General Counsel | A | Restricted Stock Units | 6365 | $0.00 | 7,406.0000 | 255,000,000 | 611.43% | 0.00% |
| May 3, 2023 | Costa Mark J | Director | A | Restricted Stock Units | 1671 | $0.00 | 1,671.0000 | 255,000,000 | 9999.99% | 0.00% |
| May 4, 2023 | Costa Mark J | Director | M | Common Stock | 468 | $0.00 | 468.0000 | 255,000,000 | 9999.99% | 0.00% |
| April 6, 2023 | Yep Gregory L | EVP, Chief Scientific Officer | M | Restricted Stock Units | 2665 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| April 6, 2023 | Yep Gregory L | EVP, Chief Scientific Officer | F | Common Stock | 733 | $91.45 | 5,768.0000 | 255,000,000 | 11.28% | 0.00% |
| April 6, 2023 | Yep Gregory L | EVP, Chief Scientific Officer | M | Common Stock | 2665 | $0.00 | 6,501.0000 | 255,000,000 | 69.47% | 0.00% |
| April 6, 2023 | Fauchon de Villeplee Christophe | President, Scent | M | Common Stock | 913 | $0.00 | 11,065.0000 | 255,000,000 | 8.99% | 0.00% |
| April 6, 2023 | Fauchon de Villeplee Christophe | President, Scent | M | Purchased Restricted Stock Units | 1188 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| April 6, 2023 | Fauchon de Villeplee Christophe | President, Scent | M | Restricted Stock Units | 913 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| April 6, 2023 | Fauchon de Villeplee Christophe | President, Scent | M | Common Stock | 1188 | $0.00 | 10,152.0000 | 255,000,000 | 13.25% | 0.00% |
| April 1, 2023 | Herriott Simon | President Health & Biosciences | M | Common Stock | 1489 | $0.00 | 6,893.7400 | 255,000,000 | 27.55% | 0.00% |
| April 1, 2023 | Herriott Simon | President Health & Biosciences | M | Restricted Stock Units | 1489 | $0.00 | 1,489.0000 | 255,000,000 | 50.00% | 0.00% |
| April 1, 2023 | Herriott Simon | President Health & Biosciences | F | Common Stock | 461 | $90.60 | 6,432.7400 | 255,000,000 | 6.69% | 0.00% |
| April 3, 2023 | O'Byrne Kevin | Director | A | Restricted Stock Units | 262 | $0.00 | 262.0000 | 255,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | Hu Gaoxiang | Director | A | Restricted Stock Units | 434 | $0.00 | 434.0000 | 255,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | Clyburn Frank | Chief Executive Officer | F | Common Stock | 477 | $91.64 | 846.0000 | 255,000,000 | 36.05% | 0.00% |
| March 1, 2023 | Clyburn Frank | Chief Executive Officer | M | Restricted Deferred Stock Units | 1323 | $0.00 | 5,296.0000 | 255,000,000 | 19.99% | 0.00% |
| March 1, 2023 | Willoughby Dawn C | Director | A | Restricted Stock Units | 434 | $0.00 | 434.0000 | 255,000,000 | 9999.99% | 0.00% |
| March 1, 2023 | Clyburn Frank | Chief Executive Officer | M | Common Stock | 1323 | $0.00 | 1,323.0000 | 255,000,000 | 9999.99% | 0.00% |
| Feb. 19, 2023 | Johnson Jennifer Amy | EVP, General Counsel | F | Common Stock | 293 | $96.13 | 4,418.0000 | 255,000,000 | 6.22% | 0.00% |
| Feb. 19, 2023 | Johnson Jennifer Amy | EVP, General Counsel | M | Restricted Stock Units | 708 | $0.00 | 1,041.0000 | 255,000,000 | 40.48% | 0.00% |
| Feb. 19, 2023 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 584 | $0.00 | 1,341.0000 | 255,000,000 | 30.34% | 0.00% |
| Feb. 19, 2023 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 176 | $96.13 | 6,077.0000 | 255,000,000 | 2.81% | 0.00% |
| Feb. 19, 2023 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 584 | $0.00 | 6,253.0000 | 255,000,000 | 10.30% | 0.00% |
| Feb. 19, 2023 | Herriott Simon | President Health & Biosciences | M | Restricted Stock Units | 617 | $0.00 | 2,978.0000 | 255,000,000 | 17.16% | 0.00% |
| Feb. 19, 2023 | Herriott Simon | President Health & Biosciences | F | Common Stock | 177 | $96.13 | 5,367.7560 | 255,000,000 | 3.19% | 0.00% |
| Feb. 19, 2023 | Herriott Simon | President Health & Biosciences | M | Common Stock | 617 | $0.00 | 5,544.7560 | 255,000,000 | 12.52% | 0.00% |
| Feb. 19, 2023 | Johnson Jennifer Amy | EVP, General Counsel | M | Common Stock | 708 | $0.00 | 4,711.0000 | 255,000,000 | 17.69% | 0.00% |
| Feb. 1, 2023 | Costa Mark J | Director | A | Restricted Stock Units | 468 | $0.00 | 468.0000 | 255,000,000 | 9999.99% | 0.00% |
| Jan. 24, 2023 | DUCKER MICHAEL L | Director | M | Stock Equivalent Unit | 2210 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| Jan. 24, 2023 | DUCKER MICHAEL L | Director | M | Common Stock | 2210 | $0.00 | 9,877.6380 | 255,000,000 | 28.82% | 0.00% |
| Dec. 31, 2022 | MIRZAYANTZ NICOLAS | President, Nourish | D | Purchased Restricted Stock Units | 1962 | $0.00 | 2,600.0000 | 0 | 43.01% | 0.00% |
| Dec. 31, 2022 | MIRZAYANTZ NICOLAS | President, Nourish | D | Restricted Stock Units | 1843 | $0.00 | 1,701.0000 | 0 | 52.00% | 0.00% |
| Jan. 3, 2023 | Strzelecki Angela | President, Pharma Solutions | F | Common Stock | 487 | $105.64 | 5,669.0000 | 255,000,000 | 7.91% | 0.00% |
| Jan. 3, 2023 | Strzelecki Angela | President, Pharma Solutions | M | Common Stock | 1341 | $0.00 | 6,156.0000 | 255,000,000 | 27.85% | 0.00% |
| Jan. 3, 2023 | Fauchon de Villeplee Christophe | President, Scent | M | Common Stock | 784 | $0.00 | 8,964.0000 | 255,000,000 | 9.58% | 0.00% |
| Jan. 3, 2023 | Fauchon de Villeplee Christophe | President, Scent | M | Restricted Stock Units | 784 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| Jan. 3, 2023 | Fortanet Francisco | EVP, Operations | M | Purchased Restricted Stock Units | 5254 | $0.00 | 0.0000 | 255,000,000 | 100.00% | 0.00% |
| Jan. 3, 2023 | Fortanet Francisco | EVP, Operations | F | Common Stock | 2229 | $103.11 | 20,297.0790 | 255,000,000 | 9.90% | 0.00% |
| Jan. 3, 2023 | Fortanet Francisco | EVP, Operations | M | Common Stock | 5254 | $0.00 | 22,526.0790 | 255,000,000 | 30.42% | 0.00% |
| Jan. 3, 2023 | Strzelecki Angela | President, Pharma Solutions | M | Restricted Stock Units | 1341 | $0.00 | 1,925.0000 | 255,000,000 | 41.06% | 0.00% |